Is quality related to quantity: Interpreting the results of STRASS in the context of noncompliant radiotherapy

The role of radiation therapy in the multimodality treatment of retroperitoneal sarcoma is evolving. In this edition of Cancer, Haas et al reported that nearly 35% of the radiotherapy plans in the investigative arm of the STRASS trial were noncompliant, emphasizing the importance of radiotherapy quality-assurance programs.

Automated summary

The role of radiation therapy in multimodality treatment of retroperitoneal sarcoma is evolving, emphasizing the importance of quality-assurance programs in radiotherapy.